70370-1060 : Ingrezza 60 mg Oral Capsule
| NDC: | 70370-1060 |
| Labeler: | Neurocrine Biosciences, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Ingrezza |
| Dosage Form: | Oral Capsule |
| Application #: | NDA209241 |
| Rev. Date: |
NDC Package Codes:
- 70370-1060-1: 30 CAPSULE IN 1 BOTTLE (70370‑1060‑1)
Active Ingredients:
- Valbenazine Tosylate
Dosage Strength:
- 60 mg
Pharmaceutical Classes:
- Vesicular Monoamine Transporter 2 Inhibitor [EPC]
- Vesicular Monoamine Transporter 2 Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 70370-1040 Ingrezza 40 mg Oral Capsule by Neurocrine Biosciences, Inc.
- 70370-1048 Ingrezza Oral Kit by Neurocrine Biosciences, Inc.
- 70370-1080 Ingrezza 80 mg Oral Capsule by Neurocrine Biosciences, Inc.
- 70370-2040 Ingrezza 40 mg Oral Capsule by Neurocrine Biosciences, Inc.
- 70370-2046 IngrezzaIngrezza Oral Kit by Neurocrine Biosciences, Inc.
- 70370-2048 IngrezzaIngrezza Oral Kit by Neurocrine Biosciences, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70370-1048Next: 70370-1080 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.